Advocacy program to increase cervical cancer screening
A Hybrid Implementation-Effectiveness Trial of Game Changers for Cervical Cancer Prevention in Uganda
This study is testing a new program to see if group sessions can help women encourage others in their social circles to get screened for cervical cancer.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 1400 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Rand Academic / other |
| Locations | 1 site (Kampala) |
| Trial ID | NCT06010160 on ClinicalTrials.gov |
What this trial studies
This randomized controlled trial evaluates the Game Changers for Cervical Cancer Prevention (GC-CCP) program, which aims to enhance cervical cancer screening advocacy among women who have previously been screened (index participants) and their social network members who have not been screened (alter participants). The intervention consists of six weekly group sessions focusing on reducing stigma, sharing experiences, and building advocacy skills. The study will take place at four clinics, with participants followed up at six and twelve months to assess the impact of the intervention on screening uptake and advocacy engagement. The trial will also explore factors that may influence the effectiveness of the intervention.
Who should consider this trial
Good fit: Ideal candidates include women who have been screened for cervical cancer in the past year and are willing to share their experiences with others.
Not a fit: Patients with advanced stage cervical cancer or those who have previously been screened for cervical cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could significantly increase cervical cancer screening rates among women who have previously not been screened.
How similar studies have performed: Other studies have shown success with community-based interventions for increasing cancer screening rates, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * screened for cervical cancer in the past year (index participants only) * has shared cervical cancer screening experience with at least one adult female social network member whom is believed to not have been screening for cervical cancer; or she reports that there is at least one female social network member who has not screened and she would feel comfortable disclosing her personal screening experience to her (index participants only) * is a member of social network of enrolled participant (social network member participants only) Exclusion Criteria: * advanced stage cervical cancer (index participants only) * screened for cervical cancer in the past (1st degree social network member participants only)
Where this trial is running
Kampala
- Makerere University School of Public Health — Kampala, Uganda (Recruiting)
Study contacts
- Principal investigator: Glenn Wagner, PhD — Rand
- Study coordinator: Glenn Wagner, PhD
- Email: gwagner@rand.org
- Phone: 3103930411
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.